RecallRadar

FDA Drug recall D-0709-2026

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed…

On 2026-07-29 the FDA classified a Class II recall of Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed… by Major Pharmaceuticals, citing subpotent Drug.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0709-2026
ClassificationClass II
Statusongoing
Initiated2026-07-13
Published2026-07-29
Last updated2026-09-13 11:52 UTC
CompanyMajor Pharmaceuticals
DistributionUS

Product

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3560-0; NDC Blister: 0904-6951-61

Reason

Subpotent Drug

Identifiers

ndc55154-3558-0
ndc55154-3559-0
ndc55154-3560-0
ndc55154-4309-0
ndc55154-3561-0
ndc55154-3562-0
ndc55154-3563-0
ndc0904-6949-61
ndc0904-6950-61
ndc0904-6951-61
ndc0904-6952-61
ndc0904-6953-61
ndc0904-6954-61
ndc0904-6955-61
ndc0904-6956-61
ndc0904-6957-61
code_infoBag lot #: N02172A, N02172B, Exp. Date 07/2026; N02288A, N02288B, Exp. Date 12/2026; Blister lot #: N02172, Exp. Date 07/2026; N02288, Exp. Date 12/2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0709-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.